Bendazac

CAS No. 20187-55-7

Bendazac( Bendazolic acid | AF-983 )

Catalog No. M21078 CAS No. 20187-55-7

Bendazac is an anticataract drug. It may act by preventing protein denaturation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 37 In Stock
100MG Get Quote In Stock
200MG 32 In Stock
500MG 49 In Stock
1G 72 In Stock

Biological Information

  • Product Name
    Bendazac
  • Note
    Research use only, not for human use.
  • Brief Description
    Bendazac is an anticataract drug. It may act by preventing protein denaturation.
  • Description
    Bendazac is an anticataract drug. It may act by preventing protein denaturation.(In Vitro):Bendazac is an anti-inflammatory agent endowed with protein antidenaturant properties effective for various inflammatory skin conditions. Bendazac has been shown to be a strong reacting substrate in a chemical oxidizing system, which mimics a physiological pathway of hydroxy radical generation.By using EPR spectroscopy of spin-labelled bovine serum albumin (BSA), Bendazac was shown to prevent the BSA denaturation induced by urea, heat and free radicals produced in the xanthine/xanthine oxidase system.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Bendazolic acid | AF-983
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    20187-55-7
  • Formula Weight
    282.29
  • Molecular Formula
    C16H14N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:56 mg/mL (198.38 mM)
  • SMILES
    O=C(O)COc1nn(Cc2ccccc2)c2ccccc12
  • Chemical Name
    2-((1-benzyl-1H-indazol-3-yl)oxy)acetic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Marques C Ramalho J S Pereira P et al. Bendazac decreases in vitro glycation of human lens crystallins. Decrease of in vitro protein glycation by bendazac[J]. Documenta Ophthalmologica 1995 90(4):395-404.
molnova catalog
related products
  • CNX-1351

    CNX-1351 is a potent and isoform-selective targeted covalent PI3Kα inhibitor.

  • Eupatoriochromene

    Eupatoriochromene retard seed germination , reduced radicle and hypocotyl growth of weed and crop plant seedlings and increased adventitious root formation of mung bean cuttings. Eupatoriochromene has insecticidal activity, it exhibits toxicity againstCulex pipiens (house mosquito) larvae andOncopeltus fasciatus (large milkweed bug) nymphs.

  • PJ34

    PJ34 HCl is the hydrochloride salt of PJ34, which is a PARP inhibitor with EC50 of 20 nM and is equally potent to PARP1/2.